Provided by Tiger Trade Technology Pte. Ltd.

Lexaria Bioscience Corp

2.89
-0.3250-10.12%
Volume:127.11K
Turnover:385.35K
Market Cap:4.77M
PE:-0.56
High:3.47
Open:3.28
Low:2.80
Close:3.21
52wk High:23.25
52wk Low:2.80
Shares:1.65M
Float Shares:1.61M
Volume Ratio:1.07
T/O Rate:7.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.1429
EPS(LYR):-9.9189
ROE:-162.77%
ROA:-81.30%
PB:1.01
PE(LYR):-0.29

Loading ...

Sep 09, 2026

Major Issues Report

Form 8-K - Current report
Sep 01, 2026

Major Issues Report

Form 8-K - Current report
Aug 17, 2026

Major Issues Report

Form 8-K - Current report
Aug 10, 2026

Major Issues Report

Form 8-K - Current report
Jul 30, 2026

Major Issues Report

Form 8-K - Current report
Jul 13, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 13, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 06, 2026

Major Issues Report

Form 8-K - Current report
Jan 28, 2026

Major Issues Report

Form 8-K - Current report
Jan 28, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 14, 2026

Delisting

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Jan 13, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dec 17, 2025

Major Issues Report

Form 8-K - Current report
Dec 06, 2025

Correspondence

Form CORRESP - Correspondence
Dec 05, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Nov 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Oct 14, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Sep 29, 2025

Major Issues Report

Form 8-K - Current report
Sep 25, 2025

Major Issues Report

Form 8-K - Current report
Jul 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]